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Abstract
Background: Concern about the completeness of comorbidity information in hospital records has been raised as a
limitation of using hospital discharge data for research. The aim of this study is to assess the impact of additional
comorbidity information from prior hospital admissions on estimation of prevalence and modelling of risk factors
for obstetric haemorrhage.
Methods: A range of chronic disease prevalence for 53,438 women who had their first birth in New South Wales
(NSW), Australia, 2005-2006, were ascertained for up to five years prior to the birth admission (for pregnancy, 2-, 3-,
4- and 5-year periods) and obstetric haemorrhage was identified from maternal hospital records for 2005 and 2006.
Results: The ascertainment of chronic disease prevalence increased with increasing length of lookback. However,
the rate of the increase was slower after 2 to 3 years than for the more recent periods. The effect size of chronic
diseases on obstetric haemorrhage risk decreased with the increased case ascertainment associated with longer
lookback. Furthermore, longer lookback did not improve the predictive capacity (C-statistic: 0.624) of a model that
was based only on the birth admission records.
Conclusions: Longer ascertainment periods resulted in improved identification of chronic disease history among
pregnant women, but the additional information from prior admissions did little to improve the modelling of risk
factors for obstetric haemorrhage.
Background
The use of population health data for health and health
outcomes research is increasing. These routinely col-
lected data may be administrative, surveillance, registry
or vital statistics collections and have the common fea-
ture of including information on an entire population.
However, concerns about the completeness of comor-
bidity information in the admission of interest (index
record) have been raised as a limitation of using hospital
discharge data for research [1]. One reason that comor-
bidity information is under-ascertained from hospital
records is that only diagnoses affecting the current
admission are required to be coded in the discharge
summary, so unrelated chronic illnesses may not be
recorded [2]. However, through record linkage it is pos-
s i b l et oe v a l u a t eap a t i e n t ’s hospitalisation history in
detail. Records belonging to the same individual can
increasingly be longitudinally linked. The term that
refers to identifying disease prevalence from health
records that precede the record or event of interest is
‘lookback’ [3].
Using a longer lookback period for ascertaining a con-
dition is likely to result in a higher proportion of sub-
jects with the condition, but the effect of the condition
m a yb er e d u c e db e c a u s et h es e v e r i t yo ft h ec o n d i t i o n
can vary depending on how recently it was identified
[4]. Few studies have assessed the impacts of different
lookback periods on ascertaining comorbidities, and
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comorbidity score in modelling of in-hospital or post-
hospital mortality or readmission [3,5-8]. Little is known
about the most appropriate lookback period for ascer-
taining comorbidities with regard to disease prevalence
and risk estimation, predictive ability and statistical
modelling of other outcomes. This is especially true in
pregnancy which usually occurs among women who are
relatively young and healthy. In Australia, 14% of female
hospitalizations are related to pregnancy and childbirth.
To date, lookback studies have been limited to older
populations and the utility of the approach in pregnancy
is unknown.
Worldwide, obstetric haemorrhage is a leading cause of
maternal mortality and accounts for about 25% of all
maternal deaths [9]. Increased rates of haemorrhage fol-
lowing childbirth have been observed in recent years in
Australia, Canada, USA and Scotland [10]. Risk factors
for obstetric haemorrhage include chronic diseases,
advanced maternal age, obesity, cesarean section, multi-
ple births, and induction and augmentation of labor
[11-13]. Obstetric haemorrhage is therefore a suitable
outcome to use for examining the effect of different look-
back periods on ascertainment of risk factors and their
prediction of subsequent outcome. In this study, we used
longitudinally linked hospital discharge records to (1)
assess impacts of different lookback periods on ascertain-
ment of chronic disease history in pregnant women and
(2) examine effects of increased ascertainment on model-
ling of risk factors for obstetric haemorrhage.
Methods
Study population and data sources
In the State of New South Wales (NSW), Australia,
comprehensively linked perinatal population data were
available from 1 July, 2000 to 31 December, 2006.
Details of the record linkage were reported in a previous
s t u d y[ 1 4 ] .F o rt h ec u r r e n ts t u d yw es e l e c t e dap o p u l a -
tion of pregnant women with five years of lookback and
focused on women in their first pregnancy. Women
with a previous pregnancy would have prior maternal
admissions and might therefore have more opportunities
for identification of chronic diseases in hospital data
than women without a previous pregnancy. Study sub-
jects included 55,002 women who had their first birth in
NSW during 1 July, 2005 to 31 December, 2006. These
women were identified from the NSW Midwives Data
Collection (’birth data’). The birth data contain informa-
tion on all births in NSW, including number of previous
births, maternal health (including pre-existing hyperten-
sion), pregnancy, labour, delivery and perinatal out-
comes. The birth data include information on live births
or stillbirths of at least 20 weeks gestation or at least
400 grams birth weight.
The NSW Admitted Patient Data Collection (’hospital
data’) covers every inpatient admission in NSW, and
includes demographic and episode-related data. Data
from the medical records are coded according to the
tenth revision of the International Classification of Dis-
eases Australian Modification (ICD-10-AM) and the
affiliated Australian Classification of Health Interven-
tions [15]. Up to 20 diagnoses and 20 procedures were
used for disease identificati o ni nt h i ss t u d y .F i g u r e1
presents the selection procedure of study subjects and
hospital records. This study was approved by the NSW
Population and Health Services Research Ethics
Committee.
Ascertainment of diseases
We selected chronic diseases including cardiac diseases,
chronic renal disease, asthma/chronic obstructive
pulmonary disease (COPD), psychiatric disorders,
135,259 hospital records from
01/07/2000 – 30/06/2007 
Excluded 1,564 women without corresponding birth admission 
records
Limited to 5 years before and 42 days after the birth
55,002 women had 1
st birth during 
01/07/2005 to 31/12/2006 
53,438 women with first birth and 113,478 hospital records (58,209 before birth 
admission and 53,438 at birth admission including 1,831 transfers prior to discharge) 
Figure 1 Selection procedures for the study women and their hospital records.
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disorders and autoimmune diseases, for the study. The
autoimmune diseases include Crohn’s disease, ulcera-
tive colitis, lupus, idiopathic, thrombocytopenic pur-
pura, multiple sclerosis,p s o r i a s i s ,a u t o i m m u n e
thyroiditis, rheumatoid diseases, Coeliac disease, vascu-
litis, pernicious anemia, myasthenia gravis, autoim-
mune hepatitis, ankylosing spondylitis, polymyositis
and primary biliary cirrhosis. There is some evidence
suggesting increased risk of obstetric haemorrhage
associated with cardiac disease, pre-existing hyperten-
sion, asthma and thyroid disorders [11,16-18]. Based
on biological plausibility, and since it is not clear that
others have investigated potential associations with
obstetric haemorrhage, renal disease, psychiatric disor-
ders, diabetes and autoimmune diseases were also
included as potential risk factors for haemorrhage.
Given that there are relatively few population-based
studies of risk factors for obstetric haemorrhage and
that the chronic diseases are relatively rare among
pregnant women, our large sample of pregnancies
represented an ideal opportunity to investigate poten-
tial influence of other chronic diseases on haemorrhage
risk. These diseases were chosen because their chronic
nature means that they would still be present at the
time of the birth regardless of the lookback period
chosen.
The ICD-10-AM diagnosis and affiliated procedure
codes for these chronic diseases are presented in
Table 1 in the Appendix. Cardiac diseases with an acute
onset, such as acute myocardial infarction, other acute
ischemic heart diseases, acute pericarditis, acute and
subacute endocarditis, acute myocarditis, cardiac arrest
and heart failure, were excluded if first identified from
the birth admission records. This is because the identi-
fied diseases may be the complications of pregnancy and
it is only appropriate to include diseases that are present
before the birth admission. We used maternal hyperten-
sion information that was recorded in either the birth
data or the hospital data at birth to improve ascertain-
ment of this condition [19].
In this study, obstetric haemorrhage (refer to as ‘hae-
morrhage’) was identified from maternal hospital records
for the birth admission and any associated transfer to
another hospital prior to discharge home. A case of hae-
morrhage was determined if a record had any diagnosis
code for postpartum haemorrhage (O72), intrapartum
haemorrhage (O67), placenta previa with haemorrhage
(O44.1), antepartum haemorrhage (O46.0), morbidly
adherent placenta (O43.2), transfusion (Z51.3) or acute
post-haemorrhage anaemia (D62); any procedure code for
transfusions (13706-01,13706-02,13706-03,92061-00 or
92062-00) or in case of vaginal birth any procedure code
for manual removal of placenta (90482-00 or 90483-00).
Table 1 ICD10-AM diagnose and procedure codes for the eight chronic diseases
Diseases ICD10-AM codes
Cardiac diseases Diagnoses: I00-02, I05-09, I10-I15, I20-25, I26-28, I30-52, O90.3, Q20-Q25 (when assessing the birth admission
records codes such as I21, I24, I30, I33, I40, I46 and I50 were excluded)
Procedure: 38603-00, 38600-00, 38256-00, 38256-01, 38256-02, 38278-00, 38278-01, 38284-00, 90202-00, 38470-
00, 38473-00, 38281-01, 38281-02, 38281-03, 38281-04, 38281-05, 38281-06, 38281-07, 38281-07, 38281-08, 38281-
09, 38281-10, 38281-00, 38278-02, 38456-07, 90203-00, 38284-01, 90219-00, 38281-11, 38281-12, 38212-00, 38209-
00, 38200-00, 38203-00, 38206-00, 35324-00, 35315-00, 35315-01, 35304-01, 35305-00, 35304-00, 35305-01, 35310-
00, 35310-01, 35310-03, 35310-04, 35310-02, 35310-05 (assessed only on hospital records before the birth
admission)
Chronic kidney disease Diagnoses: E10.2, E11.2, E12.2, E13.2, E14.2, I12-13, I15.0, I15.1, N00-08, N11-12, N14-16, N18-19, N25-28, N39.1,
N39.2, Q60-63, T82.4, T86.1, Z49, Z94.0, Z99.2
Procedure: 36561-00, 36503-00, 36503-01, 13100-06, 13100-07, 13100-08, 13100-00 (assessed only on hospital
records before the birth admission)
Asthma/Chronic obstructive
pulmonary disease
Diagnoses: J40-J47, J98, R05
Psychiatric disorders Diagnoses: F20-F25, F28-F34, F38, F39, F53.1
Pre-existing hypertension Diagnoses: O10, O11, I10-I15 or chronic hypertension* in birth data
Pre-existing diabetes Diagnoses: O24.0-O24.3, E10-E14 (excluded records that were also coded with O24.4)
Thyroid disorders Diagnoses: E00-E07, E89.0, O90.5
Procedure: 30075-03, 30094-10, 30296-00, 30297-00, 30297-01, 30306-00, 30308-00, 30309-00, 30310-00, 36503-
01, 90041-00, 90046-00, 90046-01, 90047-00, 90047-01, 90047-02 (assessed only on hospital records before the
birth admission)
Autoimmune diseases^ Diagnoses: K50, K51, M32, L93, D69.3, G35, L40, E06.3, M05, M06, K90.0, I77.6, I80, L95, M30, M31, D51.0, G70.0,
K75.4, M08.1, M45, M33.2, K74.3, M33.0, M33.1
Obstetric haemorrhage
& Diagnoses: O72, O67, O46.0, O44.1, O43.2, Z51.3, D62
Procedure: 13706-01, 13706-02, 13706-03, 92061-00, 92062-00, 90482-00, 90483-00
*Chronic hypertension tickbox (recorded in the NSW Midwives Data Collection): ^ Include Crohn’s disease, ulcerative colitis, lupus, idiopathic, thrombocytopenic
purpura, multiple sclerosis, psoriasis,
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The proportion of women with the selected chronic dis-
ease was calculated for different lengths of lookback,
with the longer lookback periods including all condi-
tions reported in the shorter periods: ‘Birth’ -a tb i r t h
admission (day 0), ‘Pregnancy’ - from day 0 back to the
estimated 1
st day of pregnancy, ‘2 years’ -f r o md a y0
back to 2 years, ‘3 years’ - from day 0 back to 3 years, ‘4
years’ - from day 0 back to 4 years and ‘5y e a r s ’ -f r o m
day 0 back to 5 years. The first day of pregnancy was
estimated by baby’sd a t eo fb i r t hm i n u s7×g e s t a t i o n
age (ranged from 18 to 44 weeks) that was recorded in
the birth record. Potential risk factors for obstetric hae-
morrhage such as type of hospital, baby’s gender, birth
weight, multiple birth, gestational age, maternal age and
combination of onset of labour and mode of delivery
were obtained from the birth record where they are reli-
ably reported [20].
Logistic regression was employed to determine the
effect size (odds ratio) of a potential risk factor on hae-
morrhage after adjusting for maternal age. In the selec-
tion of independent risk factors, age was always retained
in the model and a backwards elimination approach was
used to progressively remove the least significant term
until all terms remaining were significant (P < 0.05,
two-sided). The capacity of a model to predict haemor-
rhage was evaluated using the area under the receiver-
operating characteristic (ROC) curve (C-statistic), with
values of 1.0 representing perfect ability and 0.5 indicat-
ing no better ability than chance. For comparing corre-
lated C-statistics, we used %roc SAS
® macro [21] (a
nonparametric approach based on generalized U-Statis-
tics [22]).
Results
Of 55,002 women with a first birth from 1 July 2005
through 31 December 2006, 53,438 (97.2%) linked to a
birth admission record and were included in the study
(Figure 1). A total of 111,647 hospital records including
admissions in the five years prior to (n = 58,209) and
the birth admission records (n = 53,438) were used to
ascertain chronic diseases for the 53,438 women, giving
a median of two records per woman (range: 1 to 263;
interquartile: 1 to 3). Of the 53,438 women with a mean
age of 28.8 (SD 5.7) years, 47.9% had one record (the
birth admission), 22.2% had two records, 11.2% had
three records, 6.2% had four records, 3.6% had five
records and 9.0% had six or more records. Table 2 pre-
sents numbers of women and hospital records for each
ascertainment period. In addition to the birth admis-
sions, 1,831 women were transferred to another hospital
prior to discharge from the hospital system, and both
the birth and record subsequent to transfer were used
for identifying haemorrhage (Figure 1). From these
55,269 records, 5,047 (9.4%) women were determined to
have haemorrhage according to the definition of this
study.
The numbers of these chronic diseases ascertained
from different lookback periods are presented in Table
3. In this sample, asthma/COPD was the disease with
the highest prevalence (2.35%) while the thyroid disor-
ders had the lowest prevalence (0.51%). The proportion
of all cases that were ascertained from the birth admis-
sion records (=No. of cases from ‘Birth’/No. of cases
from ‘5y e a r s ’) differed by disease from 17.8% for
chronic renal disease to 82.0% for pre-existing diabetes.
For all chronic diseases, the prevalence increased with
increasing length of lookback period. However, the rate
of the increase was much slower after 2 to 3 years than
for the more recent periods. The additional (case) ascer-
tainment from year 4 to year 5 (i.e. [number at year 5 -
number at year 4]/number at year4) was small, ranging
from 0.5% for pre-existing hypertension to 6.8% for
asthma/COPD.
Based on birth admission records only and after
adjusting for maternal age, significant risk factors for
haemorrhage were cardiac disease (OR 1.55, 95% CI:
1.03 to 2.33; P = 0.04), chronic renal disease (OR 3.00,
95% CI: 1.71 to 5.26; P <0 . 0 0 1 )a n dp s y c h i a t r i cd i s o r -
ders (OR 1.67, 95% CI: 1.22 to 2.27; P = 0.001) (Table
4). However, cardiac disease was not statistically signifi-
c a n tw h e nw ei n c l u d e dc a s e sa s c e r t a i n e df r o mh o s p i t a l
Table 2 Numbers of women and hospital records for each ascertainment period
Time sequence No. (%) of women
(N = 53,438)
No. (%) of hospital records
(N = 113,478)
Transfer admission* 1,806 (3.4%) 1,831 (1.6%)
At birth admission 53,438 (100%) 53,438 (47.1%)
During pregnancy 15,284 (28.6%) 25,351 (22.3%)
Estimated day preceding pregnancy to <2 years prior to delivery 9,845 (18.4%) 16,640 (14.7%)
2 to <3 years prior to delivery 4,662 (8.7%) 6,930 (6.1%)
3 to <4 years prior to delivery 3,672 (6.9%) 5,158 (4.5%)
4 to <5 years prior to delivery 2,954 (5.5%) 4,130 (3.6%)
* Hospital records for any associated transfer to another hospital after the delivery but prior to discharge home.
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For these three diseases, the effect size decreased consis-
tently with increasing length of lookback period. For the
other five diseases presented in Table 3, there was only
a small change in the effect size from one lookback per-
iod to another despite the identification of more women
with the condition. For example, for pre-existing dia-
betes age-adjusted OR based on lookback period of
‘Birth’, ‘Pregnancy’, ‘2 years’, ‘3 years’, ‘4 years’ or ‘5
years’ was 1.06, 1.12, 1.10, 1.15, 1.14 and 1.12 respec-
tively; and for pre-existing hypertension was 1.22, 1.18,
1.17, 1.16, 1.15 and 1.14 respectively (Table 4).
In multivariate analysis, only chronic renal disease
(adjusted OR 2.85, 95% CI: 1.58 to 5.12; P <0 . 0 0 1 )a n d
psychiatric disorders (adjusted OR 1.48, 95% CI: 1.08 to
2.02; P = 0.01) were independent risk factors for hae-
morrhage using the birth admission records. These
results were adjusted for type of hospital, baby’sg e n d e r ,
birth weight, multiple birth, gestational age, maternal
age and combination of onset of labor and mode of
delivery (Table 5). This model has a C-statistic of 0.624.
The predictive ability did not improve with any exten-
sion of the lookback period for ascertaining the two dis-
eases (all P > 0.29), and the C-statistic remained about
the same (0.624) for models using hospital records from
lookback periods of ‘Pregnancy’, ‘2y e a r s ’, ‘3 years’, ‘4
years’ and ‘5 years’. This was also the case when com-
paring to a model that included two variables (i.e. one
Table 3 Cumulative frequency and relative frequency of cases ascertained at different lookback periods and the
prevalence of diseases for the 53,438 women by disease type
Lookback period:
’Birth’’ Pregnancy’’ 2 years’’ 3 years’’ 4 years’’ 5 years’
Cardiac diseases
No. 194 273 357 392 425 445
% of total cases 43.6% 61.3% 80.2% 88.1% 95.5% 100.0%
Prevalence 0.36% 0.51% 0.67% 0.73% 0.80% 0.83%
Chronic renal disease
No. 67 217 279 324 354 377
% of total cases 17.8% 57.6% 74.0% 85.9% 93.9% 100.0%
Prevalence 0.13% 0.41% 0.52% 0.61% 0.66% 0.71%
Asthma/COPD*
No. 473 682 984 1,087 1,175 1,255
% of total cases 37.7% 54.3% 78.4% 86.6% 93.6% 100.0%
Prevalence 0.89% 1.28% 1.84% 2.03% 2.20% 2.35%
Psychiatric disorders
No. 325 424 619 705 783 829
% of total cases 39.2% 51.1% 74.7% 85.0% 94.5% 100.0%
Prevalence 0.61% 0.79% 1.16% 1.32% 1.47% 1.55%
Pre-existing hypertension
No. 420 515 535 540 546 549
% of total cases 76.5% 93.8% 97.4% 98.4% 99.5% 100.0%
Prevalence 0.79% 0.96% 1.00% 1.01% 1.02% 1.03%
Pre-existing diabetes
No. 250 265 289 297 300 305
% of total cases 82.0% 86.9% 94.8% 97.4% 98.4% 100.0%
Prevalence 0.47% 0.50% 0.54% 0.56% 0.56% 0.57%
Thyroid disorders
No. 173 204 240 253 266 275
% of total cases 62.9% 74.2% 87.3% 92.0% 96.7% 100.0%
Prevalence 0.32% 0.38% 0.45% 0.47% 0.50% 0.51%
Autoimmune diseases^
No. 202 247 323 374 401 426
% of total cases 47.4% 58.0% 75.8% 87.8% 94.1% 100.0%
Prevalence 0.38% 0.46% 0.60% 0.70% 0.75% 0.80%
* Chronic obstructive pulmonary disease
^ Include Crohn’s disease, ulcerative colitis, lupus, idiopathic, thrombocytopenic purpura, multiple sclerosis, psoriasis, autoimmune thyroiditis, rheumatoid
diseases, Coeliac disease, vasculitis, pernicious anemia, myasthenia gravis, autoimmune hepatitis, ankylosing spondylitis, polymyositis and primary biliary cirrhosis
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period) for each of the two chronic diseases (C-statistic
0.624 vs 0.624, P = 0.95). Both additional variables were
not statistically significant in the model (both P > 0.71).
Discussion
This study showed that longer ascertainment periods
resulted in improved identification of chronic disease
history among pregnant women. Surprisingly, extension
of the lookback period up to five years for chronic dis-
eases did not increase the estimated risk effect of any
predictions of haemorrhage, and contributed little to the
performance of the haemorrhage predictive model.
These results indicate that the effort of accessing pre-
vious hospital records for the completeness of comor-
bidity information is not always worthwhile.
As anticipated, the ascertainment rate of a chronic
disease in this and other studies [6] increased progres-
sively with increasing length of the lookback period. We
hoped that a five-year ascertainment period for a
chronic disease would give good estimation of the popu-
lation prevalence in the study of young and generally
healthy women. In this study, the population prevalence
of chronic renal disease in young women in NSW was
estimated to be around 0.7% based on a five-year ascer-
tainment period. This is within the range of internation-
ally reported prevalence (0.5 to 1.3%) [23-26]. The rate
of 0.8% for cardiac diseases (mainly congenital heart dis-
ease in this population) in this study also appears to
provide a good estimate of the population prevalence.
Congenital heart disease occurs in approximately 1% of
newborn babies worldwide [27] and about 80% of
Table 4 Age-adjusted
&odds ratio (OR) for potential predictors of obstetric haemorrhage for different lookback periods
Type of diseases Lookback periods:
’Birth’’ Pregnancy’’ 2 years’’ 3 years’’ 4 years’’ 5 years’
Cardiac diseases
OR (95% CI) 1.55
(1.03-2.33)
1.45
(1.02-2.07)
1.42
(1.04-1.93)
1.34
(0.99-1.81)
1.28
(0.95-1.72)
1.21
(0.90-1.63)
P value 0.04 0.04 0.03 0.06 0.11 0.21
Chronic renal disease
OR (95% CI) 3.00
(1.71-5.26)
1.68
(1.16-2.45)
1.58
(1.13-2.22)
1.49
(1.08-2.06)
1.45
(1.07-1.99)
1.42
(1.05-1.92)
P value <0.001 0.007 0.008 0.02 0.02 0.02
Psychiatric disorders
OR (95% CI) 1.67
(1.22-2.27)
1.50
(1.13-1.98)
1.36
(1.07-1.73)
1.30
(1.03-1.63)
1.28
(1.02-1.59)
1.24
(1.00-1.54)
P value 0.001 0.005 0.01 0.03 0.03 0.05
Pre-existing hypertension
OR (95% CI) 1.22
(0.90-1.65)
1.18
(0.89-1.55)
1.17
(0.89-1.54)
1.16
(0.88-1.52)
1.15
(0.87-1.51)
1.14
(0.87-1.50)
P value 0.20 0.25 0.25 0.28 0.32 0.35
Pre-existing diabetes
OR (95% CI) 1.06
(0.70-1.60)
1.12
(0.76-1.66)
1.10
(0.76-1.61)
1.15
(0.80-1.66)
1.14
(0.79-1.64)
1.12
(0.77-1.61)
P value 0.79 0.52 0.61 0.46 0.49 0.56
Asthma/COPD*
OR (95% CI) 1.22
(0.92-1.63)
1.20
(0.94-1.53)
1.19
(0.98-1.46)
1.16
(0.95-1.41)
1.13
(0.94-1.37)
1.09
(0.90-1.31)
P value 0.18 0.15 0.09 0.14 0.20 0.37
Thyroid disorders
OR (95% CI) 1.38
(0.88-2.16)
1.39
(0.92-2.10)
1.41
(0.97-2.06)
1.38
(0.95-2.00)
1.39
(0.97-2.00)
1.34
(0.93-1.92)
P value 0.16 0.12 0.07 0.09 0.07 0.11
Autoimmune diseases^
OR (95% CI) 1.34
(0.88-2.04)
1.31
(0.89-1.92)
1.23
(0.87-1.73)
1.17
(0.84-1.62)
1.23
(0.90-1.68)
1.24
(0.92-1.67)
P value 0.17 0.17 0.24 0.35 0.19 0.17
& Age was divided into three groups: 15-19, 20-34 and ≥35 and treated as a categorical variable in the analyses.
* Chronic obstructive pulmonary disease
^ Include Crohn’s disease, ulcerative colitis, lupus, idiopathic, thrombocytopenic purpura, multiple sclerosis, psoriasis, autoimmune thyroiditis, rheumatoid
diseases, Coeliac disease, vasculitis, pernicious anemia, myasthenia gravis, autoimmune hepatitis, ankylosing spondylitis, polymyositis and primary biliary cirrhosis
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The prevalence of 0.6% for pre-existing diabetes in this
study is similar to the population prevalence of 0.7% in
Australian women aged <45 years, 2004 to 2005 [29].
The rate of 0.51% for thyroid disorders in this study is
similar to the estimated rate of clinical hypothyroidism
or hyperthyroidism in the USA (0.43%), although the
majority of thyroid disease is subclinical [30,31].
However, our study indicated that the prevalence of
some diseases (i.e. asthma and chronic hypertension)
was under-estimated. This is likely to be related to the
fact that hospital data only identifies diseases/conditions
that require hospitalisation or that affect a hospital
admission. Although lookback over 5 years increased
the identification of asthma from 0.9% to 2.4%, this still
represents poor identification of women with asthma.
The National Health Survey 2004-05 reported that
13.5% of Australian women aged 15 to 45 years had
asthma and 3% of the population had COPD (emphy-
sema and/or bronchitis) [32]. Similarly a validation
s t u d yo f1 1 8 4p r e g n a n tw o m e ni nN S Wr e p o r t e dt h e
prevalence of asthma to be 12% in pregnancy and the
sensitivity of the recording of asthma as a comorbidity
during maternal birth admissions was only 12.3% [33].
The prevalence of chronic hypertension (1% with ≥2
years of lookback) is lower than the prevalence of anti-
hypertensive drug use in 25 to 34 year olds in NSW in
1999 (1.4%), but 26.3% of pregnant women were < 25
years in our population [34]. Other limitations of using
longitudinally linked hospital records included missing
ascertainment periods (e.g. migration or admission to
hospitals outside NSW) and outpatient data, the
assumption of disease chronicity and changes in diag-
nostic criteria for a disease over time.
With regard to predictive ability, information from
prior hospital admissions might not improve the
Table 5 Independent risk factors of obstetric haemorrhage and C-statistics
Model 1* (n = 53,191): Model 2**(n = 53,191):
Covariates: OR (95%CI) P OR (95%CI) P
Chronic renal diseases (yes) 2.85 (1.58-5.12) <0.001 1.63 (1.11-2.40) 0.01
Psychiatric disorders (yes) 1.48 (1.08-2.02) 0.01 1.38 (1.04-1.84) 0.03
Baby’s gender (female) 1.15 (1.09-1.22) <0.001 1.15 (1.09-1.22) <0.001
Birth weight (per 100 g) 1.05 (1.05-1.06) <0.001 1.05 (1.05-1.06) <0.001
Multiple births (yes) 2.28 (1.86-2.78) <0.001 2.27 (1.86-2.78) <0.001
Gestational age <0.001 <0.001
Preterm (20 - 36 weeks) 2.11 (1.85-2.40) 2.12 (1.86-2.41)
Term (37 - 41 weeks) 1.00 1.00
Postterm (≥42 weeks) 0.99 (0.82-1.19) 0.99 (0.82-1.20)
Maternal age 0.11 0.10
<20 years 1.03 (0.92-1.15) 1.02 (0.91-1.15)
20 - 34 years 1.00 1.00
≥35 years 1.10 (1.01-1.19) 1.10 (1.01-1.19)
Onset of labor + mode of delivery <0.001 <0.001
Elective CS^ (no labor) 1.07 (0.96-1.20) 1.08 (0.96-1.20)
Emergency CS + induction/augmentation 0.87 (0.78-0.98) 0.88 (0.78-0.98)
Instrumental + induction/augmentation 1.99 (1.81-2.19) 1.99 (1.82-2.19)
Vaginal + induction/augmentation 1.43 (1.31-1.56) 1.43 (1.31-1.56)
Emergency CS (spontaneous labor) 0.77 (0.67-0.90) 0.77 (0.67-0.90)
Instrumental (spontaneous labor) 1.58 (1.40-1.77) 1.58 (1.41-1.77)
Vaginal (spontaneous labor) 1.00 1.00
Type of hospital (tertiary vs. other) 1.54 (1.45-1.64) <0.001 1.54 (1.45-1.64) <0.001
C-statistic (95% CI) C-statistic (95% CI)
Predictive ability 0.6240 (0.6157-0.6322) 0.6238 (0.6156-0.6320)
P for comparing the two correlated C statistics: 0.61
* Using ‘Birth’ records
** Using ‘Pregnancy’ records
^ Cesarean section
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Page 7 of 9capacity of a predictive model if it were simply used to
increase the number of cases with a condition. In a
study of 61,815 patients, Kim and Ahn [5] reported no
significant improvement in the predictive capacity of in-
hospital mortality of a model with 3-years inpatient
comorbidity score (either Elixhauser or Charlson) com-
pared to a model with 1-year inpatient comorbidity
s c o r e .Z h a n ge ta l .[ 3 ]a l s or e p o r t e dt h a tm o d e l sf o r1 -
year mortality prediction among elderly patients using
1-year inpatient Charlson score or 2-years inpatient
Charlson score were almost identical. Extra cases identi-
fied from prior admissions might be less severe or at an
early stage of the illness but are treated equally to the
cases from the index admission in the analysis. This
might explain the finding of no improvement in the sta-
tistical performance by this and other studies.
On the other hand, Zhang et al. [3] found increased
predictive capacity if comorbidity information from year
1 and year 2 inpatient records for the Charlson score
were entered separately into the model. Preen et al. [6]
reported similar findings, and found that C-statistics for
1-year mortality prediction in medical patients and pro-
cedural patients were 0.892 and 0.917 respectively for a
model with a comorbidity score of the index admission
and increased to 0.900 and 0.923 respectively for a
model with two comorbidity scores: one for the index
admission and another for 5-year prior admissions. In
another study of the contribution to model performance
in predicting in-hospital mortality made by extra infor-
mation from a 3-year lookback period, Stukenborg et al.
[8] reported that comorbidity risk adjustment (either
Deyo/Charlson or Elixhauser method) achieved the best
performance in various groups of hospital patients when
comorbidity information from the index and prior
admissions were treated as separate covariates in a
model. Nevertheless, they also concluded that ascertain-
ing information from prior admissions provided little
improvement in the explanatory power of risk adjust-
ment methods. Using information from the index and
prior admissions as independent indicators might allow
the model to distinguish late-stage from early-stage
cases because more severe cases were more likely to be
ascertained more than once and thus produce some
improvement in the statistical performance.
With regard to effect estimation, increasing the num-
ber of cases with a disease/condition by using informa-
tion from prior hospital admissions could produce an
effect size smaller than that estimated using only the
index record (i.e. only severe or active cases). In this
study we found that the more remote (in time) that hos-
pitalisations with chronic disease were reported, the
smaller the effect the disease had on haemorrhage. One
explanation for this could be that conditions that were
ascertained from previous hospital records might have
been treated and well controlled or be less severe than
conditions identified from the index records. The effect
of a risk factor on a particular outcome is likely to be
dependent not only on the risk factor but also its sever-
ity, and a more severe instance is more likely to be
ascertained in recent records than in older records [35].
Not much additional comorbidity information had been
gained in this generally young and healthy population
using a longer lookback period. Thus, this study indi-
cates that the findings of lookback studies may not be
generalisable between young and older populations.
Chronic renal disease (via anemia) and psychiatric dis-
orders (via medication) may place women at increased
risk of obstetric haemorrhage [36]. Pregnant women
with chronic renal disease or treated psychiatric disor-
ders which complicate the pregnancy or are associated
with hospitalisation during the pregnancy should be
considered to be at risk of haemorrhage and be treated
accordingly.
Conclusions
A five-year ascertainment period for a chronic disease
improves estimation of the population prevalence in a
young and generally healthy population if the disease
required treatment in hospital. On the other hand, dis-
eases that do not require hospitalisation or cases with
no obvious symptoms or in subclinical categories would
usually not be picked up using longitudinally linked hos-
pital records. In the case of haemorrhage prediction,
comorbidity information from prior hospital admissions
did little to improve the haemorrhage modelling. For
estimating the effect size of a risk factor, the most
appropriate lookback period should be determined by
the study objective.
Acknowledgements
We thank the NSW Department of Health for access to the population
health data and the NSW Centre for Health Record Linkage for linking the
data sets. Funding for this project was provided by the Outcomes, Services
and Policy for the Reproductive and Early Years, a population health capacity
building grant from the Australian National Health and Medical Research
Council (NHMRC). JSC and JBF are supported by the NHMRC Capacity
Building Grant. The NHMRC supports CLR with a Senior Research Fellowship.
Author details
1Clinical and Population Perinatal Health Research, Kolling Institute of
Medical Research, Sydney Medical School, University of Sydney, Sydney,
Australia.
2Sydney School of Public Health, University of Sydney, Sydney,
Australia.
Authors’ contributions
JSC performed the statistical analysis and drafted the manuscript. CLR and
JBF conceived of the study, participated in its design and revised it critically
for important intellectual content. JMS contributed to the study design,
statistical analysis and interpretation of the results. All authors read and
approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Chen et al. BMC Medical Research Methodology 2011, 11:68
http://www.biomedcentral.com/1471-2288/11/68
Page 8 of 9Received: 5 October 2010 Accepted: 17 May 2011
Published: 17 May 2011
References
1. SF Jencks, DK Williams, TL Kay, Assessing hospital-associated deaths from
discharge data. The role of length of stay and comorbidities. JAMA. 260,
2240–2246 (1988). doi:10.1001/jama.260.15.2240
2. LI Iezzoni, SM Foley, J Daley, J Hughes, ES Fisher, T Heeren, Comorbidities,
complications, and coding bias. Does the number of diagnosis codes
matter in predicting in-hospital mortality? JAMA. 267, 2197–2203 (1992).
doi:10.1001/jama.267.16.2197
3. JX Zhang, TJ Iwashyna, NA Christakis, The performance of different
lookback periods and sources of information for Charlson comorbidity
adjustment in Medicare claims. Med Care. 37, 1128–1139 (1999).
doi:10.1097/00005650-199911000-00005
4. LG Shack, B Rachet, EM Williams, JM Northover, MP Coleman, Does the
timing of comorbidity affect colorectal cancer survival? A population based
study. Postgrad Med J. 86,7 3 –78 (2010). doi:10.1136/pgmj.2009.084566
5. KH Kim, LS Ahn, A comparative study on comorbidity measurements with
lookback period using health insurance database: focused on patients who
underwent percutaneous coronary intervention. J Prev Med Public Health.
42, 267–273 (2009). doi:10.3961/jpmph.2009.42.4.267
6. DB Preen, CD Holman, K Spilsbury, JB Semmens, KJ Brameld, Length of
comorbidity lookback period affected regression model performance of
administrative health data. J Clin Epidemiol. 59, 940–946 (2006).
doi:10.1016/j.jclinepi.2005.12.013
7. D Sarfati, S Hill, G Purdie, E Dennett, T Blakely, How well does routine
hospitalisation data capture information on comorbidity in New Zealand? N
Z Med J. 123,5 0 –61 (2010)
8. GJ Stukenborg, DP Wagner, AF Connors, Comparison of the performance of
two comorbidity measures, with and without information from prior
hospitalizations. Medical Care. 39, 727–739 (2001). doi:10.1097/00005650-
200107000-00009
9. World Health Organization, The World Health Report 2005 - make every
mother and child count.http://www.who.int/whr/2005/en/index.html
10. M Knight, WM Callaghan, C Berg, S Alexander, MH Bouvier-Colle, JB Ford,
KS Joseph, G Lewis, RM Liston, CL Roberts, J Oats, J Walker, Trends in
postpartum hemorrhage in high resource countries: a review and
recommendations from the International Postpartum Hemorrhage
Collaborative Group. BMC Pregnancy Childbirth. 9, 55 (2009). doi:10.1186/
1471-2393-9-55
11. JB Ford, CL Roberts, JM Simpson, J Vaughan, CA Cameron, Increased
postpartum hemorrhage rates in Australia. Int J Gynaecol Obstet. 98,
237–243 (2007). doi:10.1016/j.ijgo.2007.03.011
12. RW Stones, CM Paterson, NJ Saunders, Risk factors for major obstetric
haemorrhage. Eur J Obstet Gynecol Reprod Biol. 48,1 5 –18 (1993).
doi:10.1016/0028-2243(93)90047-G
13. CG Sosa, F Althabe, JM Belizan, P Buekens, Risk factors for postpartum
hemorrhage in vaginal deliveries in a Latin-American population. Obstet
Gynecol. 113, 1313–1319 (2009)
14. JS Chen, CL Roberts, JB Ford, LK Taylor, JM Simpson, Cross-sectional
reporting of previous cesarean birth was validated using longitudinal linked
data. J Clin Epidemiol. 63, 672–678 (2010). doi:10.1016/j.jclinepi.2009.08.019
15. National Centre for Classification in Health, Australian Coding standards for
ICD-10-AM and ACHI. National Centre for Classification in Health, University
of Sydney, Sydney. (2004)
16. S Alexander, L Dodds, BA Armson, Perinatal outcomes in women with
asthma during pregnancy. Obstet Gynecol. 92, 435–440 (1998). doi:10.1016/
S0029-7844(98)00191-4
17. LE Davis, KJ Leveno, FG Cunningham, Hypothyroidism complicating
pregnancy. Obstet Gynecol. 72, 108–112 (1988)
18. SC Siu, M Sermer, DA Harrison, E Grigoriadis, G Liu, S Sorensen, JF
Smallhorn, D Farine, KS Amankwah, JC Spears, JM Colman, Risk and
predictors for pregnancy-related complications in women with heart
disease. Circulation. 96, 2789–2794 (1997)
19. CL Roberts, JC Bell, JB Ford, RM Hadfield, CS Algert, JM Morris, The accuracy
of reporting of the hypertensive disorders of pregnancy in population
health data. Hypertens Pregnancy. 27, 285–297 (2008). doi:10.1080/
10641950701826695
20. LK Taylor, S Travis, M Pym, E Olive, DJ Henderson-Smart, How useful are
hospital morbidity data for monitoring conditions occurring in the perinatal
period? Aust N Z J Obstet Gynaecol. 45,3 6 –41 (2005). doi:10.1111/j.1479-
828X.2005.00339.x
21. SAS Institute, Nonparametric comparison of areas under correlated ROC
curves.http://support.sas.com/kb/25/017.html
22. ER DeLong, DM DeLong, DL Clarke-Pearson, Comparing the areas under
two or more correlated receiver operating characteristic curves: a
nonparametric approach. Biometrics. 44, 837–845 (1988). doi:10.2307/
2531595
23. M Cirillo, M Laurenzi, M Mancini, A Zanchetti, C Lombardi, NG De Santo,
Low glomerular filtration in the population: prevalence, associated
disorders, and awareness. Kidney Int. 70, 800–806 (2006). doi:10.1038/sj.
ki.5001641
24. ZY Li, GB Xu, TA Xia, HY Wang, Prevalence of chronic kidney disease in a
middle and old-aged population of Beijing. Clin Chim Acta. 366, 209–215
(2006). doi:10.1016/j.cca.2005.10.011
25. J Coresh, D Byrd-Holt, BC Astor, JP Briggs, PW Eggers, DA Lacher, TH
Hostetter, Chronic kidney disease awareness, prevalence, and trends among
U.S. adults, 1999 to 2000. J Am Soc Nephrol. 16, 180–188 (2005)
26. QL Zhang, D Rothenbacher, Prevalence of chronic kidney disease in
population-based studies: systematic review. BMC Public Health. 8, 117
(2008). doi:10.1186/1471-2458-8-117
27. MA Gatzoulis, L Swan, J Therrien, GA Pantley, Adult Congenital Heart
Disease: A Practical Guide. (Blackwell Publishing Ltd. London, 2005)
28. HP Nieminen, EV Jokinen, HI Sairanen, Late results of pediatric cardiac
surgery in Finland: a population-based study with 96% follow-up.
Circulation. 104, 570–575 (2001). doi:10.1161/hc3101.093968
29. Australian Institute of Health and Welfare, Diabetes prevalence in Australia:
An assessment of national data sources. Cat. no. CVD 46. (Canberra, 2009)
30. Y Aoki, RM Belin, R Clickner, R Jeffries, L Phillips, KR Mahaffey, Serum TSH
and total T4 in the United States population and their association with
participant characteristics: National Health and Nutrition Examination Survey
(NHANES 1999-2002). Thyroid. 17, 1211–1223 (2007). doi:10.1089/
thy.2006.0235
31. JG Hollowell, NW Staehling, WD Flanders, WH Hannon, EW Gunter, CA
Spencer, LE Braverman, Serum TSH, T(4), and thyroid antibodies in the
United States population (1988 to 1994): National Health and Nutrition
Examination Survey (NHANES III). J Clin Endocrinol Metab. 87, 489–499
(2002). doi:10.1210/jc.87.2.489
32. The Australian Institute of Health and Welfare, Australia’s health 2008. Cat.
no. AUS 99. (Canberra, 2008)
33. RM Hadfield, SJ Lain, CA Cameron, JC Bell, JM Morris, CL Roberts, The
prevalence of maternal medical conditions during pregnancy and a
validation of their reporting in hospital discharge data. Aust N Z J Obstet
Gynaecol. 48,7 8 –82 (2008). doi:10.1111/j.1479-828X.2007.00818.x
34. E Barr, A Cameron, J Shaw, P Zimmet, The Australian Diabetes Obesity and
Lifestyle Study (AusDiab): Five year follow-up Results for New South Wales.
http://www.health.nsw.gov.au/resources/publichealth/surveys/au_diab_obes.
pdf (2005)
35. M Donaghy, CL Chang, N Poulter, Duration, frequency, recency, and type of
migraine and the risk of ischaemic stroke in women of childbearing age. J
Neurol Neurosurg Psychiatry. 73, 747–750 (2002). doi:10.1136/jnnp.73.6.747
36. E Salkeld, LE Ferris, DN Juurlink, The risk of postpartum hemorrhage with
selective serotonin reuptake inhibitors and other antidepressants. J Clin
Psychopharmacol. 28, 230–234 (2008). doi:10.1097/JCP.0b013e318166c52e
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2288/11/68/prepub
doi:10.1186/1471-2288-11-68
Cite this article as: Chen et al.: Use of hospitalisation history (lookback)
to determine prevalence of chronic diseases: impact on modelling of
risk factors for haemorrhage in pregnancy. BMC Medical Research
Methodology 2011 11:68.
Chen et al. BMC Medical Research Methodology 2011, 11:68
http://www.biomedcentral.com/1471-2288/11/68
Page 9 of 9